UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004069
Receipt number R000004901
Scientific Title Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer
Date of disclosure of the study information 2010/10/01
Last modified on 2020/08/26 13:52:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer

Acronym

Biomarker Study in Gastrointestinal Cancer

Scientific Title

Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer

Scientific Title:Acronym

Biomarker Study in Gastrointestinal Cancer

Region

Japan


Condition

Condition

Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer,

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify plasma peptide biomarkers which correlate with adverse events or tumor response in chemotherapy for gastrointestinal cancer.

Basic objectives2

Others

Basic objectives -Others

Using plasma samples collected before start of chemotherapy, we will try to identify peptide biomarkers which correlate with adverse events or tumor response in chemotherapy for gastrointestinal cancer.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification and clinical application of predictors of tumor response and adverse events in GI cancer chemotherapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histologically confirmed esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, and biliary tract cancer
2) Receiving cancer chemotherapy
3) No prior treatment with anti-cancer agents and radiation
4) Adequate organ function
5) Written informed consent

Key exclusion criteria

1) Chemoradiation except for esophageal cancer treatment
2) Active infectious disease
3) Ileus
4) Severe diarrhea
5) Interstitial pneumonia
6) Severe diabetes
7) Under treatment for unstable angina or myocardial infarction
8) Metastasis to central nervus system
9) Massive ascites or pleural effusion
10) Dementia
11) Other inappropriate cases according to primary doctor's evaluation

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Muto

Organization

Kyoto University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

606-8507

Address

54 Shogoinkawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-4319

Email

mmuto@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Junichi
Middle name
Last name Matsubara

Organization

Kyoto University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

606-8507

Address

54 Shogoinkawahara-cho, Sakyo-ku, Kyoto

TEL

075-751-3518

Homepage URL


Email

jmatsuba@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology and Hepatology, Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology and Hepatology, Kyoto University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University IRB

Address

54 Shogoinkawahara-cho, Sakyo-ku, Kyoto

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院(京都府)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 01 Day


Related information

URL releasing protocol

N/A

Publication of results

Unpublished


Result

URL related to results and publications

http://www.kyotocbrc.kuhp.kyoto-u.ac.jp/cbrc/about/

Number of participants that the trial has enrolled

100

Results

This research has been included into the projects in the Kyoto University Clinical Bio-resource Center.

Results date posted

2020 Year 08 Month 26 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

N/A

Participant flow

N/A

Adverse events

N/A

Outcome measures

N/A

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 08 Month 16 Day

Date of IRB

2010 Year 06 Month 30 Day

Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

in analysis


Management information

Registered date

2010 Year 08 Month 19 Day

Last modified on

2020 Year 08 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name